Table 1 Basic patient characteristics. For each disease group, summary statistics are shown. Values are presented as average (minimum/maximum); for gender, numbers for female/male patients are displayed
Disease (n) | Gender | Age (years) | Preparation (minutes) | Disease duration (days) | Applied treatments (n) |
|---|---|---|---|---|---|
NIND (10) | 8/2 | 43 (22/85) | 35 (20/50) | 15.8 (0/74) | Acetazolamide (1), topiramate (1), no therapy (8) |
CIS-RRMS (18) | 16/2 | 35 (20/52) | 46 (28/100) | 19.4 (0/133) | Interferon beta (1), no therapy (17) |
SPMS (8) | 4/4 | 54 (40/68) | 42 (25/60) | 202 (62/343) | Mitoxantrone (3), rituximab (1), no therapy (4) |
Lues (6) | 0/6 | 41 (26/52) | 48 (8/110) | 0.9 (0/1.5) | Penicillin (3), ceftriaxone (1), no therapy (2) |
LNB (13) | 1/12 | 54 (19/80) | 49 (30/85) | 4.2 (0/31) | No therapy (3), all other patient treated with drugs including ceftriaxone, ampicillin, meropenem, amnd doxycycline |
Bacterial meningistis (10) | 5/5 | 59 (24/88) | 49 (35/65) | 7.2 (0.5/40.5) | All patient treated with drugs including ampicillin, gentamicin, ceftriaxone, vancomycin, penicillin, meropenem, isoniazid, rifampicin, streptomycin, cotrimoxazol, moxifloxacin, amoxicillin, and clavulanic acid |
Viral meningitis (10) | 5/5 | 52 (34/73) | 47 (30/60) | 6.7 (0/24) | 1 patient without information, all other treated with drugs including aciclovir, ampicillin, and ceftrioxan |